NO934227L - Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse - Google Patents

Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO934227L
NO934227L NO934227A NO934227A NO934227L NO 934227 L NO934227 L NO 934227L NO 934227 A NO934227 A NO 934227A NO 934227 A NO934227 A NO 934227A NO 934227 L NO934227 L NO 934227L
Authority
NO
Norway
Prior art keywords
group
branched
therapeutic use
hydrogen atom
pyrrole derivatives
Prior art date
Application number
NO934227A
Other languages
English (en)
Other versions
NO934227D0 (no
Inventor
Mireille Sevrin
Jacques Menin
Christian Maloizel
Juan Antonio Diaz Martin
Ulpiano Martin Escudero Perez
Manuel Bedoya Zurita
Gregorio Del Sol Moreno
Maria Dolores Jimenez Bargueno
Magali Romanach Ferrer
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9214065A external-priority patent/FR2698364B1/fr
Priority claimed from FR9307538A external-priority patent/FR2706899A1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO934227D0 publication Critical patent/NO934227D0/no
Publication of NO934227L publication Critical patent/NO934227L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Pyrrolderivater med generell formel (I) hvor R1 er et hydrogenatom eller et halogenatom, en rettkjedet eller forgrenet C^-alkylgruppe, en C3.e-alkenylgruppe, en C^.4~ alkoksymetylgruppe, benzylradikalet, en fenylgruppe som eventuelt er substituert med ett eller flere halogenatomer eller alkylradikaler, en gruppe CO2R hvor R er et rettkjedet eller forgrenet C^-alkylradikal, fenylradikalet eller benzyl- radikalet, eller en gruppe CONR'R'' hvor R' og R'' hver er, uavhengig av hverandre, et hydrogenatom eller et rettkjedet eller forgrenet C^-alkylradikal, R2 er et hydrogenatom eller et halogenatom, eller en rettkjedet eller forgrenet C^- alkylgruppe, og R3 er en 4,5-dihydro-lH-imidazol-2-yl-gruppe eller lH-imidazol-4-yl-gruppe, og deres addisjonssalter med farmasøytisk tålbare syrer. Derivatene har terapeutisk anvendelse.
NO934227A 1992-11-24 1993-11-23 Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse NO934227L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9214065A FR2698364B1 (fr) 1992-11-24 1992-11-24 Dérivés de pyrrole, leur préparation et leur application en thérapeutique.
FR9307538A FR2706899A1 (en) 1993-06-22 1993-06-22 Pyrrole derivatives, their preparation and their therapeutic application

Publications (2)

Publication Number Publication Date
NO934227D0 NO934227D0 (no) 1993-11-23
NO934227L true NO934227L (no) 1994-05-25

Family

ID=26229898

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934227A NO934227L (no) 1992-11-24 1993-11-23 Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse

Country Status (16)

Country Link
US (1) US5380742A (no)
EP (1) EP0599697A1 (no)
JP (1) JPH06211869A (no)
KR (1) KR940011466A (no)
CN (1) CN1091743A (no)
AU (1) AU662846B2 (no)
CA (1) CA2109774A1 (no)
CZ (1) CZ252193A3 (no)
FI (1) FI935196A (no)
HU (1) HUT70504A (no)
IL (1) IL107726A (no)
MX (1) MX9307309A (no)
NO (1) NO934227L (no)
NZ (1) NZ250258A (no)
PL (1) PL301143A1 (no)
SK (1) SK130893A3 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719844B1 (fr) * 1994-05-10 1996-06-07 Synthelabo Dérivés de 5,6-dihydro-4h-thiéno[3,4-c]pyrrole, leur préparation et leur application en thérapeutique.
DE19514579A1 (de) 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
FR2733750B1 (fr) * 1995-05-03 1997-06-13 Synthelabo Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
CA2327543A1 (en) * 1998-05-06 1999-11-11 Duke University Method of treating bladder and lower urinary tract syndromes
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
JP2004035507A (ja) * 2002-07-05 2004-02-05 Nippon Soda Co Ltd ピロール誘導体及びその製造方法
CN101186612B (zh) * 2006-11-15 2012-10-03 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的吡咯啉衍生物及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8529546D0 (en) * 1985-11-30 1986-01-08 Beecham Group Plc Compounds
FR2652579B1 (fr) * 1989-10-02 1992-01-24 Sanofi Sa Derives d'hydroxy-2 thiophene et furanne condenses avec un cycle azote, sur procede de preparation et leur application en therapeutique.
DE4023048A1 (de) * 1990-07-20 1992-01-23 Basf Ag Dicarbonsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
AU664710B2 (en) * 1991-08-27 1995-11-30 Upjohn Company, The A method for treatment of metabolic disorders
US5252581A (en) * 1992-07-20 1993-10-12 Hoechst-Roussel Pharmaceuticals Inc. Substituted aminothienopyridines, pharmaceutical composition and use

Also Published As

Publication number Publication date
AU5183193A (en) 1994-06-09
SK130893A3 (en) 1994-11-09
NO934227D0 (no) 1993-11-23
AU662846B2 (en) 1995-09-14
FI935196A (fi) 1994-05-25
JPH06211869A (ja) 1994-08-02
CZ252193A3 (en) 1994-06-15
KR940011466A (ko) 1994-06-21
CN1091743A (zh) 1994-09-07
CA2109774A1 (fr) 1994-05-25
US5380742A (en) 1995-01-10
IL107726A (en) 1997-01-10
PL301143A1 (en) 1994-05-30
MX9307309A (es) 1994-06-30
FI935196A0 (fi) 1993-11-23
HUT70504A (en) 1995-10-30
EP0599697A1 (fr) 1994-06-01
IL107726A0 (en) 1994-02-27
HU9303322D0 (en) 1994-03-28
NZ250258A (en) 1995-07-26

Similar Documents

Publication Publication Date Title
NO933434L (no) Piperidinderivater, deres fremstilling og anvendelse
NO951266L (no) Imidazol-holdige inhibitorer for farnesyl-protein-transferase
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
IE822467L (en) Imidazole derivatives
DE3667466D1 (de) 5-(6-imidazo(1,2-a)pyridyl)pyridinderivat.
DK0632036T3 (da) Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser
AU2001272666A1 (en) 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
FI971935A0 (fi) Polyanioniset bentsyyliglykosidit sileän lihaskudoksen solujen lisääntymisen estäjinä
NO163568C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO934227L (no) Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
WO2002094770A3 (en) Aminoalcohol derivatives
NO933435L (no) Piperidinderivater, deres fremstilling og anvendelse
NO941150L (no) Tiadiazinoner
HUP9900679A2 (hu) Simaizom sejtburjánzást gátló benzimidazolszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
ES2193047T3 (es) (3,4 dihydro-2h-benzo(1,4) oxazinilmetil)(3-(1h-indol-3-il)-alquil)-aminas.
ES471895A1 (es) Procedimiento para preparar derivados de benzamidina
NO951812L (no) Pyrrolderivater, deres fremstilling og anvendelse
NO952194L (no) Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer
DE69301639D1 (de) Tetrahydronaphtalenderivate, ihre Herstellung und ihre therapeutische Verwendung
DK0461012T3 (da) Derivater af ((1-arylpyrrolidin-2-yl)methyl)piperazin, fremstillingen heraf og deres terapeutiske anvendelse
NO934566L (no) Imidazolderivater, fremgangsmåte for deres fremstilling og farmasöytisk preparat derav
MY104048A (en) New allylaminoethylazoles.
FI921298A (fi) Menetelmä lääkeaineena käyttökelpoisen 5-(6-imidatso/1,2-a/pyridyyli)pyridiini-johdannaisen valmistamiseksi